NANOBIOTIX (EPA:NANO) | WebDisclosure

PRESS RELEASE

published on 04/20/2026 at 08:30, 5 months 10 days ago

Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN delivrées par LNP après traitement avec sa technologie de nan
Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN délivrées par LNP après traitement avec sa technologie de Nanoprimer

NANOBIOTIX Immunothérapies Biodisponibilité Données Précliniques Toxicité
BRIEF

published on 04/07/2026 at 22:20, 5 months 22 days ago

Monthly Statement of Voting Rights and Capital of Nanobiotix

Share Capital Voting Rights Euronext Nasdaq NANOBIOTIX
BRIEF

published on 04/07/2026 at 22:20, 5 months 22 days ago

État Mensuel des Droits de Vote et du Capital de Nanobiotix

Droits De Vote Euronext Capital Social Nasdaq NANOBIOTIX
PRESS RELEASE

published on 04/07/2026 at 22:15, 5 months 22 days ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix publie ses données mensuelles sur les droits de vote et les actions. Détails sur la société de biotechnologie et ses activités

Euronext Paris Droits De Vote Biotechnologie Actions NANOBIOTIX
BRIEF

published on 03/30/2026 at 08:35, 6 months ago

NANOBIOTIX Reveals Initial Data from Phase 2 Lung Cancer Trial

Clinical Research Phase 2 Trial NANOBIOTIX Lung Cancer JNJ-1900 (NBTXR3)
BRIEF

published on 03/30/2026 at 08:35, 6 months ago

NANOBIOTIX dévoile les premières données de son essai de phase 2 sur le cancer du poumon

Recherche Clinique Essai De Phase 2 NANOBIOTIX Cancer Du Poumon JNJ-1900 (NBTXR3)
PRESS RELEASE

published on 03/30/2026 at 08:30, 6 months ago

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
NANOBIOTIX announces first data from phase 2 trial on JNJ-1900 for stage 3 lung cancer presented by Johnson & Johnson at European Lung Cancer Conference

Phase 2 Trial NANOBIOTIX Lung Cancer Johnson & Johnson JNJ-1900
BRIEF

published on 03/26/2026 at 21:20, 6 months 3 days ago

NANOBIOTIX publiera ses résultats financiers et sa mise à jour pour 2025

Biotechnologie Conférence Téléphonique Mise À Jour Du Marché Résultats Financiers 2025 Traitements Par Nanoparticules
BRIEF

published on 03/26/2026 at 21:20, 6 months 3 days ago

Nanobiotix Annonce la Publication de Ses Résultats Annuels 2025

Résultats Financiers Biotechnologie NANOBIOTIX Nanoparticules Conférence En Ligne
BRIEF

published on 03/26/2026 at 21:20, 6 months 3 days ago

Nanobiotix Announces the Publication of its 2025 Annual Results

Financial Results Biotechnology NANOBIOTIX Online Conference Nanoparticles

Published on 09/30/2026 at 14:37, 53 minutes ago

NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 59 minutes ago

First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week
Published on 09/30/2026 at 14:07, 1 hour 23 minutes ago

Worksport COR Energy System Now Available Through Amazon
Published on 09/30/2026 at 13:30, 2 hours ago

Nextech3D.ai Engages MZ Group to Lead Strategic Investor Relations Program
Published on 09/30/2026 at 13:00, 2 hours 30 minutes ago

Grid Metals Announces Maiden Cesium Resource at Falcon West; Establishes Lucy South Cesium Deposit as the World's Second Largest Cesium Resource in Active Development

View all ACCESSWIRE

Published on 09/30/2026 at 15:10, 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/30/2026 at 15:09, 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 09/30/2026 at 15:09, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/30/2026 at 15:08, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 09/30/2026 at 15:08, 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Rotork plc

View all EQS

Published on 09/30/2026 at 12:14, 3 hours 16 minutes ago

Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/30/2026 at 12:00, 3 hours 30 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 09/30/2026 at 12:00, 3 hours 30 minutes ago

Capital increase through exercise of subscription rights
Published on 09/30/2026 at 08:45, 6 hours 45 minutes ago

Air Liquide invests over 170 million euros to support a semiconductor leader expanding manufacturing capabilities in Japan
Published on 09/30/2026 at 08:45, 6 hours 45 minutes ago

Air Liquide investit plus de 170 millions d’euros pour accompagner un leader des semi-conducteurs dans le développement de ses capacités de production au Japon

View all LES ECHOS COMFI WIRE

News